You are currently viewing a new version of our website. To view the old version click .

Vaccines, Volume 2, Issue 4

December 2014 - 9 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (9)

  • Article
  • Open Access
22 Citations
7,191 Views
13 Pages

CD137 Enhancement of HPV Positive Head and Neck Squamous Cell Carcinoma Tumor Clearance

  • Christopher T. Lucido,
  • Paola D. Vermeer,
  • Bryant G. Wieking,
  • Daniel W. Vermeer and
  • John H. Lee

10 December 2014

Standard-of-care cisplatin and radiation therapy (CRT) provides significant tumor control of human papillomavirus (HPV)-mediated head and neck squamous cell carcinomas (HNSCCs); this effectiveness depends on CRT-mediated activation of the patient’s...

  • Review
  • Open Access
7 Citations
9,944 Views
9 Pages

Peptide Vaccines for Hypertension and Diabetes Mellitus

  • Hironori Nakagami,
  • Hiroshi Koriyama and
  • Ryuichi Morishita

26 November 2014

Vaccines are commonly used as a preventive medicine for infectious diseases worldwide; however, the trial for an amyloid beta vaccine against Alzheimer’s disease will open a new concept in vaccination. In case of therapeutic vaccines for cancer, thei...

  • Review
  • Open Access
72 Citations
16,837 Views
35 Pages

14 November 2014

Equine influenza (EI) is a major respiratory disease of horses, which is still causing substantial outbreaks worldwide despite several decades of surveillance and prevention. Alongside quarantine procedures, vaccination is widely used to prevent or l...

  • Article
  • Open Access
26 Citations
7,617 Views
13 Pages

27 October 2014

In previous studies, we demonstrated in mice and prairie dogs that simultaneous administration of two recombinant raccoon poxviruses (rRCN) expressing Yersinia pestis antigens (F1 and V307—a truncated version of the V protein) provided superior prote...

  • Editorial
  • Open Access
29 Citations
9,456 Views
12 Pages

DNA Vaccines: Recent Developments and the Future

  • Britta Wahren and
  • Margaret A. Liu

27 October 2014

This special issue is focused on DNA vaccines, marking the two decades since the first demonstration of pre-clinical protection was published in Science (Ulmer et al.; Heterologous protection against influenza by injection of DNA encoding a viral pro...

  • Review
  • Open Access
23 Citations
8,807 Views
17 Pages

17 October 2014

The LC16m8 strain of vaccinia virus, the active ingredient in the Japanese smallpox vaccine, was derived from the Lister/Elstree strain. LC16m8 is replication-competent and has been administered to over 100,000 infants and 3,000 adults with no seriou...

  • Review
  • Open Access
30 Citations
16,393 Views
20 Pages

Self-Amplifying Replicon RNA Vaccine Delivery to Dendritic Cells by Synthetic Nanoparticles

  • Kenneth C. McCullough,
  • Panagiota Milona,
  • Lisa Thomann-Harwood,
  • Thomas Démoulins,
  • Pavlos Englezou,
  • Rolf Suter and
  • Nicolas Ruggli

16 October 2014

Dendritic cells (DC) play essential roles determining efficacy of vaccine delivery with respect to immune defence development and regulation. This renders DCs important targets for vaccine delivery, particularly RNA vaccines. While delivery of interf...

  • Review
  • Open Access
92 Citations
15,986 Views
28 Pages

Overview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future

  • Claudia Maria Trombetta,
  • Daniele Perini,
  • Stuart Mather,
  • Nigel Temperton and
  • Emanuele Montomoli

13 October 2014

Serological techniques commonly used to quantify influenza-specific antibodies include the Haemagglutination Inhibition (HI), Single Radial Haemolysis (SRH) and Virus Neutralization (VN) assays. HI and SRH are established and reproducible techniques,...

  • Article
  • Open Access
19 Citations
8,201 Views
21 Pages

Enhancement of Mucosal Immunogenicity of Viral Vectored Vaccines by the NKT Cell Agonist Alpha-Galactosylceramide as Adjuvant

  • Shailbala Singh,
  • Pramod N. Nehete,
  • Guojun Yang,
  • Hong He,
  • Bharti Nehete,
  • Patrick W. Hanley,
  • Michael A. Barry and
  • K. Jagannadha Sastry

10 October 2014

Gene-based vaccination strategies, specifically viral vectors encoding vaccine immunogens are effective at priming strong immune responses. Mucosal routes offer practical advantages for vaccination by ease of needle-free administration, and immunogen...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Vaccines - ISSN 2076-393X